RT Journal Article ID 64d3fc8d3f7104bb A1 Raut, Ashlesha S. A1 Prabhu, Rashmi H. A1 Patravale, Vandana B. T1 Psoriasis Clinical Implications and Treatment: A Review JF Critical Reviews™ in Therapeutic Drug Carrier Systems JO CRT YR 2013 FD 2013-04-24 VO 30 IS 3 SP 183 OP 216 K1 Psoriasis K1 immunopathogenesis K1 clinical types K1 treatment K1 novel delivery systems AB Psoriasis is a common skin disorder affecting the population worldwide. It is a T-cell mediated autoimmune disorder leading to keratinocyte hyperproliferation. Psoriasis has genetic predisposition that is further aggravated by certain stimulating factors. In spite of significant advances in understanding the pathogenesis of psoriasis, the exact etiology of the disease remains unknown. The clinical manifestations of this disease include various forms that affect different parts of the body. Treatment options vary according to the mode of application or severity of the disease. Earlier treatments have included application of emollients or keratolytic agents to hydrate the skin or shed off the skin. But later treatments have been modified to treat the underlying T-cell proliferation. Hence, topical treatments like coal tar, vitamin D, retinoids, topical calcineurin inhibitors for treating mild psoriasis, systemic treatments including methotrexate, cyclosporine, acitretin, hydroxyurea, as well as light therapy for severe psoriasis have become more prominent. Current treatment modalities are associated with the risk of serious side effects from prolonged treatment. Combinations of these therapies have provided effective and rapid modalities to suppress the disease and reduce the side effects of treatment. In addition, newer carrier systems for conventional drugs are being developed to improve the effectiveness of treatment and reduce the side effects. Development of biologics and gene therapy have revolutionized the treatment of this skin disease. Although an array of therapies to suppress the psoriatic condition exists, none are curative. PB Begell House LK https://www.dl.begellhouse.com/journals/3667c4ae6e8fd136,2c11cd7727222f89,64d3fc8d3f7104bb.html